Skip to main content

View full-text article in PMC

. Author manuscript; available in PMC: 2017 Apr 1.

Published in final edited form as: Cancer Prev Res (Phila). 2016 Jan 26;9(4):317–323. doi: 10.1158/1940-6207.CAPR-15-0033

Table 3.

Performance of the glycan markers in combination with the protein marker pro-SFTPB.

Marker	Discovery			Test
Marker	AUC	p-value^a	FDR	AUC	p-value^a	FDR
H₃N₄	0.660	0.0066	0.0077	0.704	0.2756	0.2756
H₃N₄F₁	0.668	0.0055	0.0072	0.710	0.1141	0.1349
H₅N₄F₁	0.664	0.0121	0.0121	0.732	0.0004	0.0057
H₆N₅F₁	0.679	0.0003	0.0006	0.708	0.0864	0.1337
Tr	0.680	0.0005	0.0009	0.709	0.0948	0.1337
Gal_1	0.695	0.0001	0.0003	0.724	0.0048	0.0206
Gal_2	0.675	0.0006	0.0010	0.723	0.0046	0.0206
Gal_3	0.688	0.0003	0.0006	0.721	0.0071	0.0229
Gal_4	0.695	0.0000	0.0002	0.717	0.0508	0.1100
Gal_5	0.688	0.0003	0.0006	0.704	0.2704	0.2756
Sia_1	0.680	0.0022	0.0031	0.711	0.0206	0.0536
Sia_2	0.692	0.0001	0.0005	0.707	0.1028	0.1337
pro-SFTPB	0.634	-	-	0.699	-	-

^a

p-value obtained from the likelihood-ratio test indicating the significance of marker +proSFTPB compared to pro-SFTPB alone.